170 related articles for article (PubMed ID: 2491832)
1. Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.
Mellors JW; Debs RJ; Ryan JL
Infect Immun; 1989 Jan; 57(1):132-7. PubMed ID: 2491832
[TBL] [Abstract][Full Text] [Related]
2. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
4. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
van Dissel JT; Stikkelbroeck JJ; Michel BC; van den Barselaar MT; Leijh PC; van Furth R
J Immunol; 1987 Sep; 139(5):1673-8. PubMed ID: 2957433
[TBL] [Abstract][Full Text] [Related]
5. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.
Kagaya K; Watanabe K; Fukazawa Y
Infect Immun; 1989 Feb; 57(2):609-15. PubMed ID: 2492266
[TBL] [Abstract][Full Text] [Related]
6. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
Yoshida R; Murray HW; Nathan CF
J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
[TBL] [Abstract][Full Text] [Related]
7. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.
Langermans JA; van der Hulst ME; Nibbering PH; van Furth R
Infect Immun; 1992 Dec; 60(12):5107-12. PubMed ID: 1452344
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
9. Microbicidal activities of Salmonella typhimurium- and interferon-gamma-activated mouse peritoneal macrophages.
Langermans JA; Nibbering PH; van der Hulst ME; van Furth R
Pathobiology; 1991; 59(3):189-93. PubMed ID: 1909142
[TBL] [Abstract][Full Text] [Related]
10. Activation of human macrophages. Comparison of other cytokines with interferon-gamma.
Nathan CF; Prendergast TJ; Wiebe ME; Stanley ER; Platzer E; Remold HG; Welte K; Rubin BY; Murray HW
J Exp Med; 1984 Aug; 160(2):600-5. PubMed ID: 6206183
[TBL] [Abstract][Full Text] [Related]
11. Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity.
Langermans JA; van der Hulst ME; Nibbering PH; van der Meide PH; van Furth R
Immunology; 1992 Nov; 77(3):354-61. PubMed ID: 1478682
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
Lamperi S; Carozzi S
Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor is not involved in production of reactive nitrogen intermediates by or toxoplasmastatic activity of gamma interferon-activated murine macrophages.
Buisman A; van Dissel JT; Langermans JA; van Furth R
Infect Immun; 1994 Mar; 62(3):1121-4. PubMed ID: 8112845
[TBL] [Abstract][Full Text] [Related]
15. Fungicidal activation of murine macrophages by recombinant gamma interferon.
Beaman L
Infect Immun; 1987 Dec; 55(12):2951-5. PubMed ID: 3119493
[TBL] [Abstract][Full Text] [Related]
16. Differences in the rate of intracellular killing of catalase-negative and catalase-positive Listeria monocytogenes by normal and interferon-gamma-activated macrophages.
van Dissel JT; Stikkelbroeck JJ; van Furth R
Scand J Immunol; 1993 Apr; 37(4):443-6. PubMed ID: 8469926
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interferon gamma-induced macrophage microbicidal activity against Leishmania major by liposomes: inhibition is dependent upon composition of phospholipid headgroups and fatty acids.
Gilbreath MJ; Fogler WE; Swartz GM; Alving CR; Meltzer MS
Int J Immunopharmacol; 1989; 11(2):103-10. PubMed ID: 2495252
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Ia antigen expression on gamma interferon treated macrophages infected with Ehrlichia risticii.
Messick JB; Rikihisa Y
Vet Immunol Immunopathol; 1992 May; 32(3-4):225-41. PubMed ID: 1632064
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposomes.
Hockertz S; Franke G; Paulini I; Lohmann-Matthes ML
J Interferon Res; 1991 Jun; 11(3):177-85. PubMed ID: 1919076
[TBL] [Abstract][Full Text] [Related]
20. Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.
Roach TI; Kiderlen AF; Blackwell JM
Infect Immun; 1991 Nov; 59(11):3935-44. PubMed ID: 1937752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
